1. Home
  2. LMAT vs LGND Comparison

LMAT vs LGND Comparison

Compare LMAT & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LMAT
  • LGND
  • Stock Information
  • Founded
  • LMAT 1983
  • LGND 1987
  • Country
  • LMAT United States
  • LGND United States
  • Employees
  • LMAT N/A
  • LGND N/A
  • Industry
  • LMAT Medical/Dental Instruments
  • LGND Biotechnology: Pharmaceutical Preparations
  • Sector
  • LMAT Health Care
  • LGND Health Care
  • Exchange
  • LMAT Nasdaq
  • LGND Nasdaq
  • Market Cap
  • LMAT 2.0B
  • LGND 2.0B
  • IPO Year
  • LMAT 2006
  • LGND 1992
  • Fundamental
  • Price
  • LMAT $105.87
  • LGND $116.55
  • Analyst Decision
  • LMAT Buy
  • LGND Strong Buy
  • Analyst Count
  • LMAT 7
  • LGND 6
  • Target Price
  • LMAT $92.83
  • LGND $144.83
  • AVG Volume (30 Days)
  • LMAT 139.9K
  • LGND 141.3K
  • Earning Date
  • LMAT 10-31-2024
  • LGND 11-07-2024
  • Dividend Yield
  • LMAT 0.60%
  • LGND N/A
  • EPS Growth
  • LMAT 49.21
  • LGND 160.46
  • EPS
  • LMAT 1.82
  • LGND 2.47
  • Revenue
  • LMAT $213,029,000.00
  • LGND $152,422,000.00
  • Revenue This Year
  • LMAT $16.04
  • LGND $23.19
  • Revenue Next Year
  • LMAT $9.62
  • LGND $15.08
  • P/E Ratio
  • LMAT $58.04
  • LGND $47.17
  • Revenue Growth
  • LMAT 14.81
  • LGND N/A
  • 52 Week Low
  • LMAT $51.70
  • LGND $57.00
  • 52 Week High
  • LMAT $106.99
  • LGND $129.90
  • Technical
  • Relative Strength Index (RSI)
  • LMAT 70.41
  • LGND 54.92
  • Support Level
  • LMAT $100.45
  • LGND $109.53
  • Resistance Level
  • LMAT $104.82
  • LGND $125.76
  • Average True Range (ATR)
  • LMAT 2.95
  • LGND 5.65
  • MACD
  • LMAT 0.34
  • LGND -0.91
  • Stochastic Oscillator
  • LMAT 91.24
  • LGND 38.73

About LMAT LeMaitre Vascular Inc.

LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches, and vessel closure systems. LeMaitre generates the majority of its revenue in the United States.

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Share on Social Networks: